In one paragraphArticle in Disease models & mechanisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Anna E WebberleyCentre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.
Raquel Boque-SastreBiomedicine Division, School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.ORCID 0000-0002-0214-8848 Lauren BaileyCentre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.
Cerys CharlesCentre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.
Rachel A JonesCentre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.
Rosie Bunton-StasyshynMary Lyon Centre, Medical Research Council, Harwell, Oxfordshire, OX11 0RD, UK.ORCID 0000-0002-1895-2240 Michelle E StewartMary Lyon Centre, Medical Research Council, Harwell, Oxfordshire, OX11 0RD, UK.
David S Chateletμ-VIS X-ray Imaging Centre, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK.ORCID 0000-0002-1856-3982 Stephanie K Robinsonμ-VIS X-ray Imaging Centre, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK.ORCID 0000-0001-5436-2929 Matthew J HiggsCentre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID 0000-0002-0710-8087 Rosalind M JohnBiomedicine Division, School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.ORCID 0000-0002-3827-7617 Anthony R IslesCentre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID 0000-0002-7587-5712 Funding
Cardiff UniversityEngineering and Physical Sciences Research Council EP/T02593X/1Foundation for Prader-Willi Research EP/T02593X/1NVIDIANvidia (United Kingdom)
6 · The paper itselfAbstract
The neurodevelopmental disorder Prader-Willi syndrome (PWS) is caused by paternally derived loss of gene expression from the imprinted interval on chromosome 15q11-q13. Recently, it has been suggested that the abnormal feeding-related behaviours characteristic of PWS can, in part, be developmentally programmed in utero via abnormal placental function. Here, we report that several PWS-associated genes were expressed in mouse placenta with three PWS-associated RNA transcripts, i.e. genes Magel2 and Necdin, and the lncRNA Sngh14, colocalised to the Kdr-positive (Kdr+) foetal endothelial cells of the labyrinth zone central to nutrient transport. In a novel PWS mouse model (Large+/-) we found markedly reduced expression of PWS-associated genes in the placenta and an associated ∼25% reduction in Kdr+ foetal endothelial cells. Although this did not directly translate into a significant reduction in foetal growth late in gestation, these data suggest that placental function and nutrient transfer from mother to foetus could be compromised in PWS contributing to later post-natal phenotypes.
Indexed as
PlacentaPrader-Willi SyndromeAnimalsDisease Models, AnimalEndothelial CellsFemaleGene Expression Regulation, DevelopmentalIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMiceMice, Inbred C57BLNerve Tissue ProteinsNuclear ProteinsPregnancyRNA, MessengerRNA, Small NucleolarIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMagel2 protein, mousenecdinNerve Tissue ProteinsNuclear ProteinsRNA, MessengerRNA, Small NucleolarVascular Endothelial Growth Factor Receptor-2DevelopmentLabyrinth zoneMousePlacentaPrader–Willi syndrome
Identifiers
PMID42411013
PMCPMC13580601
What Socratic holds
Textmetadata
Read underepoch 390